KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 138 filers reported holding KEZAR LIFE SCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,441,494 | -49.9% | 2,051,676 | +3.2% | 0.44% | -41.5% |
| Q2 2023 | $4,871,159 | -17.6% | 1,988,228 | +5.3% | 0.76% | -23.0% |
| Q1 2023 | $5,910,154 | -35.7% | 1,888,228 | +44.7% | 0.99% | -49.9% |
| Q4 2022 | $9,188,446 | -14.3% | 1,305,183 | +4.8% | 1.97% | +32.4% |
| Q3 2022 | $10,726,000 | +332.8% | 1,245,806 | +315.7% | 1.49% | +461.9% |
| Q2 2022 | $2,478,000 | -20.5% | 299,654 | +59.7% | 0.26% | -39.9% |
| Q1 2022 | $3,118,000 | -44.7% | 187,599 | -44.4% | 0.44% | -28.9% |
| Q4 2021 | $5,640,000 | +956.2% | 337,293 | +387.4% | 0.62% | +749.3% |
| Q2 2019 | $534,000 | +13.1% | 69,200 | +246.0% | 0.07% | +37.7% |
| Q4 2018 | $472,000 | -89.6% | 20,000 | -90.6% | 0.05% | -89.8% |
| Q3 2018 | $4,539,000 | +15.1% | 212,000 | -7.0% | 0.52% | -4.2% |
| Q2 2018 | $3,943,000 | – | 227,900 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
| Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
| Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
| Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
| CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
| Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
| Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |